Clinical Trial Update: A Clinical Trial to Compare the Efficacy and Safety of a Combination Therapy of Ezetimibe and Rosuvastatin Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients (I-ROSETTE Study) [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing the combination of ezetimibe and rosuvastatin versus rosuvastatin alone in hypercholesterolemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• CRESTOR (Rosuvastatin)
• Zetia (ezetimibe)

Snippet

Sponsor: IlDong Pharmaceutical Co Ltd | Conditions: Hypercholesterolemia | Phase 3 | Status: COMPLETED